Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
ACTIVE_NOT_RECRUITING
Status
Conditions
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Metastatic Colorectal Carcinoma
- Metastatic Malignant Solid Neoplasm
- Metastatic Melanoma
- Metastatic Ovarian Carcinoma
- Metastatic Renal Cell Carcinoma
- Platinum-Resistant Ovarian Carcinoma
- Recurrent Melanoma
- Recurrent Renal Cell Carcinoma
- Refractory Melanoma
- Refractory Renal Cell Carcinoma
- Sarcoma
- Stage IV Colorectal Cancer AJCC v8
- Stage IV Ovarian Cancer AJCC v8
- Stage IV Renal Cell Cancer AJCC v8
Interventions
- PROCEDURE: Biopsy Procedure
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Computed Tomography
- PROCEDURE: Magnetic Resonance Elastography
- BIOLOGICAL: Pembrolizumab
- BIOLOGICAL: Ziv-Aflibercept
Sponsor
National Cancer Institute (NCI)